The Center for Innovative Drug Discovery (CIDD), a joint venture between The University of Texas at San Antonio (UTSA) and The University of Texas Health Science Center at San Antonio, has been ...
The University of Texas at San Antonio (UTSA) has been awarded a five-year $3.2 million grant from the Cancer Prevention & Research Institute of Texas (CPRIT). The money will go toward work at The ...
Taking homegrown discoveries — research findings observed in laboratories in San Antonio — and turning them into drugs to treat disease is the focus of the Center for Innovation in Drug Discovery ...
Pancreatic ductal adenocarcinoma (PDAC) is the most prevalent form of pancreatic cancer and presents a 5-year survival rate of less than 10%. Novel therapies focusing on targeting the tumor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results